Billiontoone, Inc. (NASDAQ:BLLN) Stock Has Consensus Price Target of $125.88

Shares of Billiontoone, Inc. (NASDAQ:BLLN) have earned an average recommendation of “Hold” from the eleven brokerages that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, two have given a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $126.25.

Several equities research analysts have commented on BLLN shares. Canaccord Genuity Group assumed coverage on shares of Billiontoone in a research note on Wednesday, September 2nd. They issued a “buy” rating and a $120.00 target price for the company. Wall Street Zen cut Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Guggenheim boosted their target price on shares of Billiontoone from $125.00 to $128.00 and gave the stock a “buy” rating in a report on Thursday. BTIG Research dropped their price target on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, August 6th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Billiontoone in a research note on Friday, September 18th.

Insider Activity

In related news, CEO Oguzhan Atay sold 8,333 shares of Billiontoone stock in a transaction dated Monday, September 28th. The stock was sold at an average price of $120.64, for a total transaction of $1,005,293.12. Following the completion of the transaction, the chief executive officer owned 8,333 shares in the company, valued at approximately $1,005,293.12. This trade represents a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Thomas Lynch sold 35,112 shares of the company’s stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $110.33, for a total value of $3,873,906.96. Following the completion of the sale, the insider owned 700 shares in the company, valued at $77,231. This represents a 98.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 255,107 shares of company stock valued at $29,318,494. Company insiders own 50.22% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of BLLN. MCF Advisors LLC raised its stake in Billiontoone by 330.8% in the 2nd quarter. MCF Advisors LLC now owns 448 shares of the company’s stock worth $54,000 after purchasing an additional 344 shares in the last quarter. Integrated Wealth Concepts LLC bought a new stake in shares of Billiontoone during the 2nd quarter worth $29,000. Thrive Wealth Management LLC acquired a new position in Billiontoone during the second quarter worth about $240,000. Jasper Ridge Partners L.P. bought a new stake in shares of Billiontoone during the second quarter worth $615,000. Finally, Wasatch Advisors LP increased its holdings in Billiontoone by 40.2% in the 2nd quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after purchasing an additional 148,446 shares in the last quarter.

Billiontoone Stock Performance

Shares of NASDAQ:BLLN opened at $105.76 on Friday. The company has a current ratio of 11.69, a quick ratio of 11.31 and a debt-to-equity ratio of 0.17. Billiontoone has a 1-year low of $61.96 and a 1-year high of $150.44. The stock has a market capitalization of $4.99 billion and a P/E ratio of 151.09. The business has a 50-day moving average price of $107.45 and a two-hundred day moving average price of $99.79.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 EPS for the quarter, hitting the consensus estimate of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The company had revenue of $109.45 million during the quarter. Equities analysts predict that Billiontoone will post 0.83 earnings per share for the current year.

Billiontoone Company Profile

BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company’s platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.

BillionToOne’s primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.